Anne DeGheest is managing partner at MedStars Ventures Partners. Since 1986, she has been a mentor capitalist specializing in investing and mentoring early-stage start-ups in healthcare. The life science companies for which she has been a founder or an early advisor have generated over $6 billion in market capitalization. She provided angel capital, hands-on operating expertise and/or business strategy in the founding of major companies like Pyxis (CareFusion), Aspect Medical (acquired by Covidien), VISX (acquired by AMO), Thermage (merged into Solta Medical), VISICU(acquired by Philips), Masimo (Nasdaq: MASI). She is a strategic advisor to larger corporations and has also helped grow new entrepreneurial division of large corporations like Johnson & Johnson, Baxter, Medtronic and McKesson. She was part of the founding executive team of Nellcor (a division of Covidien), MedPool.com and OmniCell (Nasdaq: OMCL). Anne founded in 2010 HealthTech Capital, a group of private investors dedicated to funding and mentoring new "HealthTech" start ups to decrease healthcare cost and empower patients. HealthTech capital is an ecosystem of angels, venture capitalists, providers and industry key players with the three sets of expertise needed to succeed in this new HealthTech space: healthcare, technology and user engagement. She founded in 2012 the HealthTech conference, the leading conference on how to build new HealthTech Companies in the changing healthcare ecosystem. She is a frequent speaker and moderator at industry conferences. Anne is a guest-lecturer on entrepreneurship and angel investing at Stanford Business School, Dartmouth Tuck and Singularity University. She has extensive private and public board experience. She was an Entrepreneur-In-Residence with Canaan Partners and Institutional Venture partners. She started her career at Raychem after receiving a MBA from Harvard and a Master in Business Engineering from University of Brussels.